Empowering Vaccine Manufacturers for Global Health Equity

We're excited to share our latest whitepaper, which dives into the production economics of vaccine manufacturing, offering actionable insights for new and existing manufacturers, especially in low- and middle-income countries (LMICs). This piece was co-authored with the Clinton Health Access Initiative (CHAI) and BDO and made possible by the Gates Foundation.

Our analysis highlights key factors influencing production costs and profitability, providing insight for sustainable, cost-effective operations. Key takeaways include the importance of scale, securing demand commitments and leveraging innovation.

Explore how these insights can transform new manufacturers into competitive players in the international vaccine landscape, contributing to global health equity and resilience.

Read the full whitepaper to learn more!